Literature DB >> 12354397

Motoneuron death triggered by a specific pathway downstream of Fas. potentiation by ALS-linked SOD1 mutations.

Cédric Raoul1, Alvaro G Estévez, Hiroshi Nishimune, Don W Cleveland, Odile deLapeyrière, Christopher E Henderson, Georg Haase, Brigitte Pettmann.   

Abstract

Death pathways restricted to specific neuronal classes could potentially allow for precise control of developmental neuronal death and also underlie the selectivity of neuronal loss in neurodegenerative disease. We show that Fas-triggered death of normal embryonic motoneurons requires transcriptional upregulation of neuronal NOS and involves Daxx, ASK1, and p38 together with the classical FADD/caspase-8 cascade. No evidence for involvement of this pathway was found in cells other than motoneurons. Motoneurons from transgenic mice overexpressing ALS-linked SOD1 mutants (G37R, G85R, or G93A) displayed increased susceptibility to activation of this pathway: they were more sensitive to Fas- or NO-triggered cell death but not to trophic deprivation or excitotoxic stimulation. Thus, triggering of a motoneuron-restricted cell death pathway by neighboring cells might contribute to motoneuron loss in ALS.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12354397     DOI: 10.1016/s0896-6273(02)00905-4

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  124 in total

Review 1.  Programmed cell death in amyotrophic lateral sclerosis.

Authors:  Christelle Guégan; Serge Przedborski
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

Review 2.  Links between electrophysiological and molecular pathology of amyotrophic lateral sclerosis.

Authors:  Katharina A Quinlan
Journal:  Integr Comp Biol       Date:  2011-10-11       Impact factor: 3.326

Review 3.  Retrograde axonal transport: pathways to cell death?

Authors:  Eran Perlson; Sandra Maday; Meng-Meng Fu; Armen J Moughamian; Erika L F Holzbaur
Journal:  Trends Neurosci       Date:  2010-04-29       Impact factor: 13.837

4.  IFNγ triggers a LIGHT-dependent selective death of motoneurons contributing to the non-cell-autonomous effects of mutant SOD1.

Authors:  J Aebischer; P Cassina; B Otsmane; A Moumen; D Seilhean; V Meininger; L Barbeito; B Pettmann; C Raoul
Journal:  Cell Death Differ       Date:  2010-11-12       Impact factor: 15.828

Review 5.  RNA-targeted Therapeutics for ALS.

Authors:  Linga V Reddy; Timothy M Miller
Journal:  Neurotherapeutics       Date:  2015-04       Impact factor: 7.620

6.  Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model.

Authors:  Francesco Paolo Di Giorgio; Monica A Carrasco; Michelle C Siao; Tom Maniatis; Kevin Eggan
Journal:  Nat Neurosci       Date:  2007-04-15       Impact factor: 24.884

7.  The slow Wallerian degeneration protein, WldS, binds directly to VCP/p97 and partially redistributes it within the nucleus.

Authors:  Heike Laser; Laura Conforti; Giacomo Morreale; Till G M Mack; Molly Heyer; Jane E Haley; Thomas M Wishart; Bogdan Beirowski; Simon A Walker; Georg Haase; Arzu Celik; Robert Adalbert; Diana Wagner; Daniela Grumme; Richard R Ribchester; Markus Plomann; Michael P Coleman
Journal:  Mol Biol Cell       Date:  2005-12-21       Impact factor: 4.138

8.  D-serine is a key determinant of glutamate toxicity in amyotrophic lateral sclerosis.

Authors:  Jumpei Sasabe; Tomohiro Chiba; Marina Yamada; Koichi Okamoto; Ikuo Nishimoto; Masaaki Matsuoka; Sadakazu Aiso
Journal:  EMBO J       Date:  2007-08-30       Impact factor: 11.598

9.  Chronic activation in presymptomatic amyotrophic lateral sclerosis (ALS) mice of a feedback loop involving Fas, Daxx, and FasL.

Authors:  C Raoul; E Buhler; C Sadeghi; A Jacquier; P Aebischer; B Pettmann; C E Henderson; G Haase
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-31       Impact factor: 11.205

10.  Delivery of AAV-IGF-1 to the CNS extends survival in ALS mice through modification of aberrant glial cell activity.

Authors:  James C Dodge; Amanda M Haidet; Wendy Yang; Marco A Passini; Mark Hester; Jennifer Clarke; Eric M Roskelley; Christopher M Treleaven; Liza Rizo; Heather Martin; Soo H Kim; Rita Kaspar; Tatyana V Taksir; Denise A Griffiths; Seng H Cheng; Lamya S Shihabuddin; Brian K Kaspar
Journal:  Mol Ther       Date:  2008-04-01       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.